Adverse clinical outcome associated with mutations that typify african American colorectal cancers

Journal of the National Cancer Institute

Volumn 108, Issue 12, 2016, Pages

  Wang, Zhenghe ^a,d   Li, Li ^a   Guda, Kishore ^a   Chen, Zhengyi ^a   Barnholtz Sloan, Jill ^a,d   Park, Young Soo ^a,d   Markowitz, Sanford D ^b,d   Willis, Joseph ^c,d  

^a Department of Genetics and Genome Sciences ^*  (United States)

^b Division of Hematology/Oncology   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN RECEPTOR A6;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BONE METASTASIS; CANCER PATIENT; CANCER RECURRENCE; COLORECTAL CANCER; DISEASE FREE SURVIVAL; GENE MUTATION; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VERY ELDERLY; CANCER STAGING; COLORECTAL TUMOR; FOLLOW UP; GENETICS; KAPLAN MEIER METHOD; METASTASIS; MIDDLE AGED; MUTATION; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TUMOR RECURRENCE;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85016060299     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djw164     Document Type: Article

References (12)

1. Agrawal S, Bhupinderjit A, Bhutani MS, et al. Colorectal cancer in African Americans. Am J Gastroenterol. 2005;100(3):515-523; discussion 514.
2. DeSantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin. 2013;63(3):151-166.
3. Gomez SL, O'Malley CD, Stroup A, et al. Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity. BMC Cancer. 2007;7: 193.
4. Polite BN, Dignam JJ, Olopade OI. Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol. 2006;24(14):2179-2187.
5. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104-117.
6. Zeng C, Wen W, Morgans AK, et al. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. JAMA Oncol. 2015;1(1):88-96.
7. Soneji S, Iyer SS, Armstrong K, et al. Racial disparities in stage-specific colorectal cancer mortality: 1960-2005. Am J Public Health. 2010;100(10):1912-1916.
8. Guda K, Veigl ML, Varadan V, et al. Novel recurrently mutated genes in African American colon cancers. Proc Natl Acad Sci U S A. 2015;112(4): 1149-1154.
9. Jayasinghe C, Simiantonaki N, Kirkpatrick CJ. Histopathological features predict metastatic potential in locally advanced colon carcinomas. BMC Cancer. 2015;15:14.
10. Morikawa T, Kuchiba A, Qian ZR, et al. Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer. Ann Surg Oncol. 2012;19(6):1944-1953.
11. Ogino S, Nosho K, Irahara N, et al. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res. 2009;15(20):6412-6420.
12. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc (Methodol). 1995;57(1): 289-300.